Frank Andersohn
Impact in
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions
-
- Pituitary Gland Disorders and Treatments
Papers in
- Toxicology 10
- Pharmacovigilance and Adverse Drug Reactions 10
-
- Medical Coding and Health Information 6
- Co-authors
- Edeltraut Garbe (34 shared papers)Samy Suissa (7 shared papers)René Schade (5 shared papers)Wilhelm Haverkamp (2 shared papers)Jochen Walker (5 shared papers)Andreas Klimpel (11 shared papers)Elisabeth Bronder (11 shared papers)Stefan N. Willich (8 shared papers)
- Journals
- Pharmacoepidemiology and Drug Safety (5 papers)European Journal of Clinical Pharmacology (5 papers)New England Journal of Medicine (2 papers)American Journal of Psychiatry (2 papers)Annals of Internal Medicine (2 papers)
- Partner nations
- GermanyCanadaUnited Kingdom
In The Last Decade
Frank Andersohn
65 papers receiving 2.8k citations
Frank Andersohn's Hit Papers
Peers
Comparison fields: 5 of 114
- Toxicology 230
- Endocrinology, Diabetes and Metabolism 429
- Pharmacology 336
- Geriatrics and Gerontology 53
- Psychiatry and Mental health 267
Countries citing papers authored by Frank Andersohn
This map shows the geographic impact of Frank Andersohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Andersohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Andersohn more than expected).
Fields of papers citing papers by Frank Andersohn
This network shows the impact of papers produced by Frank Andersohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Andersohn. The network helps show where Frank Andersohn may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank Andersohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation Hit paper breakdown → | 2007 | 582 |
| 2 | 2007 | 367 | |
| 3 | 2009 | 238 | |
| 4 | 2015 | 164 | |
| 5 | 2006 | 150 | |
| 6 | 2010 | 111 | |
| 7 | 2006 | 88 | |
| 8 | 2020 | 84 | |
| 9 | 2011 | 83 | |
| 10 | 2009 | 78 | |
| 11 | 2014 | 75 | |
| 12 | 2008 | 62 | |
| 13 | 2010 | 62 | |
| 14 | 2011 | 61 | |
| 15 | 2014 | 58 | |
| 16 | 2012 | 54 | |
| 17 | 2008 | 49 | |
| 18 | 2013 | 41 | |
| 19 | 2021 | 40 | |
| 20 | 2004 | 36 |
About Frank Andersohn
Frank Andersohn is a scholar working on Toxicology, Health Information Management, Pharmacology, Pharmacology and Neurology, having authored 68 papers that have together received 3k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Medical Coding and Health Information (6 papers), Inflammatory mediators and NSAID effects (5 papers), Blood disorders and treatments (5 papers), Substance Abuse Treatment and Outcomes (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Platelet Disorders and Treatments (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). The work is most often cited by research in Toxicology (230 citations), Endocrinology, Diabetes and Metabolism (429 citations), Pharmacology (336 citations), Geriatrics and Gerontology (53 citations) and Psychiatry and Mental health (267 citations). Frank Andersohn has collaborated with scholars based in Germany, Canada and United Kingdom. Frequent co-authors include Edeltraut Garbe, Samy Suissa, René Schade, Wilhelm Haverkamp, Jochen Walker, Andreas Klimpel, Elisabeth Bronder, Stefan N. Willich, Niklas Schmedt and Michael Thomae. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, European Journal of Clinical Pharmacology, New England Journal of Medicine, American Journal of Psychiatry and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.